ISRCTN91308077已完成不适用
Controlled, cross-sectional, follow-up study to evaluate the degree of implementation of the advance care planning program ?Beizeiten Begleiten? (care in good time) in one region?s nursing homes - RESPEKT
German National Ministry of Education and Research (German)0 个研究点目标入组 286 人开始时间: 2012年1月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 286
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •In order to examine the ACP program?s effect comprehensively, we studied the prevalence and properties of advance directives in two samples of the enrolled nursing homes:
- •Sample 1: Residents currently living in the enrolled nursing homes at the date of data collection (adults of either sex)
- •Sample 2: Random sample of residents deceased between 1 July 2010 and 31 December 2010 (adults of either sex)
排除标准
- •Residents who moved in during the last three months before data collection
研究者
相似试验
尚未招募
不适用
A non-interventional, cross-sectional study for evaluating factors relating to daily step counts and physical activity in Japanese patients with COPDJPRN-UMIN000033888AstraZeneca.KK500
尚未招募
不适用
A non-interventional, cross-sectional study for evaluating factors relating to daily step counts and physical activity in Japanese patients with COPDCOPDJPRN-UMIN000032962AstraZeneca.KK.500
进行中（未招募）
不适用
An open-label, multicenter, follow-up study to evaluate the safety and efficacy of levetiracetam (LEV) (oral tablets of 166, 250 or 500 mg b.i.d.), at individualized doses up to a maximum of 4000 mg/day (or 80 mg/kg/day for children and adolescents less than 50 kg), in children (= 4 years old), adolescents and adults suffering from primary generalized seizures - study N167EUCTR2004-001997-13-EECB SA Pharma Sector300
进行中（未招募）
不适用
An open-label, multicenter, follow-up study to evaluate the safety and efficacy of levetiracetam (LEV) (oral tablets of 166, 250 or 500 mg b.i.d.), at individualized doses up to a maximum of 4000 mg/day (or 80 mg/kg/day for children and adolescents less than 50 kg), in children (= 4 years old), adolescents and adults suffering from primary generalized seizures - PGS long-term follow-upeurology, epilepsy, primary generalized seizuresLevel: LLTClassification code 10018079EUCTR2004-001997-13-ATCB S.A. Pharma Sector300
尚未招募
1 期
Studying the effect of (music therapy) Raga Bageshri in patients prone to be diabetic (Prediabetes) comparing with previously treated prediabetic patientCTRI/2024/07/071098Sneha Santosh Banchhade